Zhongxin Finance, February 24th. On the 23rd, the Guangdong Provincial Drug Trading Center issued a notice on viewing the information related to the registration products of Guangdong Alliance Diclofenac and other drugs for centralized procurement (the first batch).
According to the above notice, the first batch of registered products that meet the application conditions for the alliance's centralized procurement contains recombinant growth hormone of multiple grades.
Image source: Screenshot of the official website of Guangdong Drug Trading Center
According to the notice issued by the Guangdong Provincial Drug Trading Center earlier on the "Guangdong Alliance Diclofenac and Other Drugs Centralized Procurement Documents", a variety of recombinant human growth hormones have been included in the centralized procurement catalog.
The alliance areas include Guangdong, Shanxi, Jiangxi, Henan, Guangxi, Hainan, Guizhou, Qinghai, Ningxia, Xinjiang, and Xinjiang Production and Construction Corps.
The application information released this time shows that companies applying for growth hormone powder injection include Anke Bio, Changchun Jinsai Pharmaceutical, Shanghai United Cell Bioengineering, Zhongshan Weiming Haiji Biomedical, and multinational pharmaceutical company Novo Nordisk. Recombinant human growth hormone injection products.
(over)